Longeveron (LGVN) Cash & Current Investments (2021 - 2026)

Longeveron's (LGVN) quarterly Cash & Current Investments came in at $15.8 million in Q1 2026, up 9.99% year-on-year from $14.3 million in Q1 2025, and up 238.08% quarter-over-quarter from $4.7 million in Q4 2025.

Longeveron (LGVN) Cash & Current Investments (2021 - 2026) Analysis & Trends

Longeveron's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $15.8 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 9.99% year-over-year to $15.8 million in Q1 2026; TTM through Mar 2026 was $15.8 million, a 9.99% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, down 75.76% from the prior year.
  • Cash & Current Investments grew to $15.8 million in Q1 2026 per LGVN's latest filing, from $4.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $22.8 million in Q3 2024 and bottomed at $2.3 million in Q1 2024.
  • The 5-year median for Cash & Current Investments is $9.8 million (2025), against an average of $10.8 million.
  • Biggest YoY gain for Cash & Current Investments was 525.36% in 2025; the steepest drop was 75.76% in 2025.
  • Year by year, Cash & Current Investments stood at $19.7 million in 2022, then plunged by 72.73% to $5.4 million in 2023, then soared by 258.74% to $19.2 million in 2024, then tumbled by 75.76% to $4.7 million in 2025, then soared by 238.08% to $15.8 million in 2026.
  • Per Business Quant, the three latest LGVN Cash & Current Investments figures stand at $15.8 million (Q1 2026), $4.7 million (Q4 2025), and $9.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Longeveron 15.18 Bn 15.16 Bn 264,000.00 15.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.76 Mn
Dec 31, 2025 4.66 Mn
Sep 30, 2025 9.24 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 14.33 Mn
Dec 31, 2024 19.23 Mn
Sep 30, 2024 22.78 Mn
Jun 30, 2024 12.40 Mn
Mar 31, 2024 2.29 Mn
Dec 31, 2023 5.36 Mn
Sep 30, 2023 3.93 Mn
Jun 30, 2023 8.66 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 19.66 Mn
Dec 31, 2021 35.04 Mn